TMB and Selected Mutations in Resectable Stage IIIA NSCLC Patients Receiving Neo-Adjuvant Chemo-Immunotherapy from NADIM Trial

被引：0

作者：

Cruz-Bermudez, A. ^{[1
]}

Casarrubios, M. ^{[1
]}

Briviesca, R. Laza ^{[1
]}

Nadal, E. ^{[2
]}

Insa, A. ^{[3
]}

Mosquera, J. ^{[4
]}

Huidobro, G. ^{[5
]}

Domine Gomez, M. ^{[6
]}

Massuti, B. ^{[7
]}

Majem Tarruella, M. ^{[8
]}

Rodriguez-Abreu, D. ^{[9
]}

Martinez-Marti, A. ^{[10
]}

De Castro Campeno, J. ^{[11
]}

Cobo Dols, M. ^{[12
]}

Lopez Vivanco, G. ^{[13
]}

Del Barco, E. ^{[14
]}

Bernabe Caro, R. ^{[15
]}

Vinolas, N. ^{[16
]}

Barneto, I. ^{[17
]}

Viteri, S. ^{[18
]}

Jove, M. ^{[2
]}

Romero, A. ^{[1
]}

Franco, F. ^{[1
]}

Provencio, M. ^{[1
]}

机构：

[1] Hosp Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Segovia de, Madrid, Spain

[2] Inst Catala Oncol, Barcelona, Spain

[3] Hosp Clin Univ Valencia, Valencia, Spain

[4] Complexo Hosp A Coruna, La Coruna, Spain

[5] Complexo Hosp Univ Vigo, Vigo, Spain

[6] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[7] Hosp Gen Univ Alicante, Alicante, Spain

[8] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[9] Univ Las Palmas Gran Canaria, Complejo Hosp Univ Insular MaternoInfantil Gran, Las Palmas Gran Canaria, Spain

[10] Hosp Univ Vall DHebron, Barcelona, Spain

[11] 2 Hosp Univ La Paz, Madrid, Spain

[12] Hosp Reg Univ Malaga, Malaga, Spain

[13] Hosp Univ Cruces, Bilbao, Spain

[14] Hosp Univ Salamanca, Salamanca, Spain

[15] Hosp Univ Virgen Del Rocio, Seville, Spain

[16] Hosp Clin Barcelona, Barcelona, Spain

[17] Hosp Univ Reina Sofia, Cordoba, Spain

[18] Quiron Dexeus Univ Inst, Inst Oncol Rosell, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期

关键词：

NADIM; TMB; neo-adjuvant chemo-immunotherapy; IIIA NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P60.07

引用

页码：S543 / S543

页数：1